CN1593522A - Chinese traditional medicinal powder for treating primary liver cancer and its preparing process - Google Patents
Chinese traditional medicinal powder for treating primary liver cancer and its preparing process Download PDFInfo
- Publication number
- CN1593522A CN1593522A CN 200410023327 CN200410023327A CN1593522A CN 1593522 A CN1593522 A CN 1593522A CN 200410023327 CN200410023327 CN 200410023327 CN 200410023327 A CN200410023327 A CN 200410023327A CN 1593522 A CN1593522 A CN 1593522A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- gained
- herba
- standby
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims description 13
- 238000000034 method Methods 0.000 title abstract description 3
- 201000007270 liver cancer Diseases 0.000 title abstract 2
- 239000008187 granular material Substances 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 241000756943 Codonopsis Species 0.000 claims description 10
- 239000000341 volatile oil Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 8
- 241000903946 Clematidis Species 0.000 claims description 7
- 241001489978 Eupolyphaga Species 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000000470 constituent Substances 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000002023 wood Substances 0.000 abstract 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000758993 Equisetidae Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010073069 Hepatic cancer Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000011279 abdominal lump Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese granule preparation for treating liver cancer, whose main compositions include Codonopsis pilosula, rhizome of Chinese paris, white atractylodes rhizome, astragalus root, dried orange peel, barbat skullcap, herba patriniae, Poria cocos, coix seed, curcuma aromatica, campeachy wood, oyster, oriental wormwood, clematis stem, nutgrass flatsedge rhizome, turtle shell, wood louse, rhubarb horsetails, peach kernel, ligumaloes, bupleurum root, and right amount of auxiliary materials. Its preparing process is also disclosed by the invention.
Description
Technical field:
The present invention relates to a kind of Chinese medicine granules and preparation technology's method thereof, relate in particular to a kind of Chinese medicine granules for the treatment of primary hepatocarcinoma and preparation method thereof.
Background technology:
Granule, changes dosage form and manages as new drug research according to the relevant laws and regulations of China's drug control as a kind of pharmaceutical dosage form.The original dosage form of this product is a tablet, has listed the national drug standards in.
The technology features of existing tablet be with prescription medical material after pulverizings, extraction etc. are handled, mixing, granulation, drying, tabletting, coating are promptly.
The Chinese medicinal tablet of existing treatment primary hepatocarcinoma exists disintegration than shortcomings such as length.
Summary of the invention:
The purpose of this invention is to provide and be easy to a kind of Chinese medicine preparation for the treatment of primary hepatocarcinoma that dissolves, absorbs and preparation method thereof, overcome the above-mentioned drawback of prior art, improve the quality and the curative effect of product, satisfy the needs of medical treatment better.
Technical solution of the present invention is a kind of Chinese medicine granules for the treatment of primary hepatocarcinoma, it is characterized in that it is that main component is the granular preparation of Radix Codonopsis, Carapax Trionycis (vinegar system), Rhizoma Paridis, the Rhizoma Atractylodis Macrocephalae (stir-fry), the Radix Astragali, Pericarpium Citri Reticulatae, Eupolyphaga Seu Steleophaga, Radix Et Rhizoma Rhei, Semen Persicae, Herba Scutellariae Barbatae, Herba Patriniae, Poria, Semen Coicis, Radix Curcumae, Lignum Sappan, Concha Ostreae, Herba Artemisiae Scopariae, Caulis Clematidis Armandii, Rhizoma Cyperi (system), Lignum Aquilariae Resinatum, Radix Bupleuri.
Main treatment is seen upward abdominal lump with disease, the pain over the hypochondriac region, and spiritlessness and weakness, lack of appetite is indigestion and loss of appetite, distension and fullness in the abdomen, susceptible to lose temper due to restlessness, the liver stasis of blood of bitter taste in the mouth and dry throat etc. is insufficiency of the spleen to be the primary hepatocarcinoma of main symptom.
The preparation method of the Chinese medicine granules of treatment primary hepatocarcinoma is:
(1) medicine constituent and percentage by weight consumption thereof are got the raw materials ready as follows:
Radix Codonopsis 2-7%, Carapax Trionycis (vinegar system) 0.5-5%, Rhizoma Paridis 2-7%, the Rhizoma Atractylodis Macrocephalae (stir-fry) 2-7%, Radix Astragali 2-7%, Pericarpium Citri Reticulatae 2-7%, Eupolyphaga Seu Steleophaga 0.5-5%, Radix Et Rhizoma Rhei 0.1-2%, Semen Persicae 1-6%, Herba Scutellariae Barbatae 2-7%, Herba Patriniae 2-7%, Poria 2-7%, Semen Coicis 2-7%, Radix Curcumae 2-7%, Lignum Sappan 2-7%, Concha Ostreae 2-7%, Herba Artemisiae Scopariae 2-7%, Caulis Clematidis Armandii 2-7%, Rhizoma Cyperi (system) 2-7%, Lignum Aquilariae Resinatum 0.5-3%, Radix Bupleuri 1-5%;
(2) get half Lignum Aquilariae Resinatum of recipe quantity and be ground into fine powder, standby;
(3) half Lignum Aquilariae Resinatum, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Herba Patriniae, Radix Curcumae, Herba Artemisiae Scopariae, Rhizoma Cyperi, radix bupleuri extract volatile oil of recipe quantity, the volatile oil beta-cyclodextrin inclusion compound, clathrate is standby; Distillation rear solution device is in addition collected, and is standby;
(4) 13 flavors such as (3) gained medicinal residues and all the other Radix Codonopsis are decocted with water twice, 2 hours for the first time, 1.5 hours for the second time, collecting decoction filtered filtrate for later use;
(5) (3) gained water liquid and (4) gained filtrate are merged, being concentrated into relative density is the clear paste of 1.10 (80 ℃ of surveys), adds ethanol, makes that to contain the alcohol amount be 50%, stir evenly, cold preservation 24 hours is got supernatant and is reclaimed ethanol, is condensed into the thick paste shape, cold drying is pulverized, and fine powder is standby;
(6) with (3) gained volatile oil clathrate compound and (5) gained extract powder and (2) gained crude drug powder, add an amount of adjuvant mix homogeneously, the system granule, cold drying, behind the granulate, granule is standby;
(7) (6) gained granule is carried out packing, promptly;
Specific embodiments:
The present invention further specifies as follows in conjunction with specific embodiments:
A kind of Chinese medicine granules for the treatment of primary hepatocarcinoma, it is to contain the granular preparation that main component is Radix Codonopsis, Carapax Trionycis (vinegar system), Rhizoma Paridis, the Rhizoma Atractylodis Macrocephalae (stir-fry), the Radix Astragali, Pericarpium Citri Reticulatae, Eupolyphaga Seu Steleophaga, Radix Et Rhizoma Rhei, Semen Persicae, Herba Scutellariae Barbatae, Herba Patriniae, Poria, Semen Coicis, Radix Curcumae, Lignum Sappan, Concha Ostreae, Herba Artemisiae Scopariae, Caulis Clematidis Armandii, Rhizoma Cyperi (system), Lignum Aquilariae Resinatum, Radix Bupleuri.
Chinese medicine granules with preparation 1000g treatment primary hepatocarcinoma is an example, and preparation method is:
(1) consumption of medicine constituent is as follows:
Radix Codonopsis 554g, Carapax Trionycis (vinegar system) 188g, Rhizoma Paridis 554g, the Rhizoma Atractylodis Macrocephalae (stir-fry) 554g, Radix Astragali 554g, Pericarpium Citri Reticulatae 554g, Eupolyphaga Seu Steleophaga 183g, Radix Et Rhizoma Rhei 94g, Semen Persicae 372g, Herba Scutellariae Barbatae 554g, Herba Patriniae 554g, Poria 554g, Semen Coicis 554g, Radix Curcumae 554g, Lignum Sappan 554g, Concha Ostreae 554g, Herba Artemisiae Scopariae 554g, Caulis Clematidis Armandii 554g, Rhizoma Cyperi (system) 554g, Lignum Aquilariae Resinatum 111g, Radix Bupleuri 277g;
(2) get half Lignum Aquilariae Resinatum of the amount of getting the raw materials ready and be ground into fine powder, standby;
(3) half Lignum Aquilariae Resinatum, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Herba Patriniae, Radix Curcumae, Herba Artemisiae Scopariae, Rhizoma Cyperi, radix bupleuri extract volatile oil of the amount of getting the raw materials ready, the volatile oil beta-cyclodextrin inclusion compound, clathrate is standby; Distillation rear solution device is in addition collected, and is standby;
(4) 13 flavors such as (3) gained medicinal residues and all the other Radix Codonopsis are decocted with water twice, 2 hours for the first time, 1.5 hours for the second time, collecting decoction filtered filtrate for later use;
(5) (3) gained water liquid and (4) gained filtrate are merged, being concentrated into relative density is the clear paste of 1.10 (80 ℃ of surveys), adds ethanol, makes that to contain the alcohol amount be 50%, stir evenly, cold preservation 24 hours is got supernatant and is reclaimed ethanol, is condensed into the thick paste shape, cold drying is pulverized, and fine powder is standby;
(6) with (3) gained volatile oil clathrate compound and (5) gained extract powder and (2) gained crude drug powder, add an amount of adjuvant mix homogeneously, the system granule, cold drying, behind the granulate, granule is standby;
(7) (6) gained granule is carried out packing, promptly;
Advantage of the present invention is:
The Chinese herbal granules for the treatment of primary carcinoma of liver is made up of medicine and excipients, and it is taken after dissolving in hot water, Be convenient to absorb, be conducive to the performance of curative effect of medication.
Claims (3)
1, a kind of Chinese medicine granules for the treatment of primary hepatocarcinoma is characterized in that it is that main constituent is the granular preparation of Radix Codonopsis, Carapax Trionycis (vinegar system), Rhizoma Paridis, the Rhizoma Atractylodis Macrocephalae (stir-fry), the Radix Astragali, Pericarpium Citri Reticulatae, Eupolyphaga Seu Steleophaga, Radix Et Rhizoma Rhei, Semen Persicae, Herba Scutellariae Barbatae, Herba Patriniae, Poria, Semen Coicis, Radix Curcumae, Lignum Sappan, Concha Ostreae, Herba Artemisiae Scopariae, Caulis Clematidis Armandii, Rhizoma Cyperi (system), Lignum Aquilariae Resinatum, Radix Bupleuri.
2, a kind of preparation method for the treatment of the Chinese medicine granules of primary hepatocarcinoma is characterized in that:
(1) medicine constituent and percentage by weight consumption thereof are got the raw materials ready as follows:
Radix Codonopsis 2-7%, Carapax Trionycis (vinegar system) 0.5-5%, Rhizoma Paridis 2-7%, the Rhizoma Atractylodis Macrocephalae (stir-fry) 2-7%, Radix Astragali 2-7%, Pericarpium Citri Reticulatae 2-7%, Eupolyphaga Seu Steleophaga 0.5-5%, Radix Et Rhizoma Rhei 0.1-2%, Semen Persicae 1-6%, Herba Scutellariae Barbatae 2-7%, Herba Patriniae 2-7%, Poria 2-7%, Semen Coicis 2-7%, Radix Curcumae 2-7%, Lignum Sappan 2-7%, Concha Ostreae 2-7%, Herba Artemisiae Scopariae 2-7%, Caulis Clematidis Armandii 2-7%, Rhizoma Cyperi (system) 2-7%, Lignum Aquilariae Resinatum 0.5-3%, Radix Bupleuri 1-5%;
(2) get half Lignum Aquilariae Resinatum of the amount of getting the raw materials ready and be ground into fine powder, standby;
(3) half Lignum Aquilariae Resinatum, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Herba Patriniae, Radix Curcumae, Herba Artemisiae Scopariae, Rhizoma Cyperi, radix bupleuri extract volatile oil of the amount of getting the raw materials ready, the volatile oil beta-cyclodextrin inclusion compound, clathrate is standby; Distillation rear solution device is in addition collected, and is standby;
(4) 13 flavors such as (3) gained medicinal residues and all the other Radix Codonopsis are decocted with water twice, 2 hours for the first time, 1.5 hours for the second time, collecting decoction filtered filtrate for later use;
(5) (3) gained water liquid and (4) gained filtrate are merged, being condensed into relative density is the clear paste of 1.10 (80 ℃ of surveys), adds ethanol, makes that to contain the alcohol amount be 50%, stir evenly, cold preservation 24 hours is got supernatant and is reclaimed ethanol, is condensed into the thick paste shape, cold drying is pulverized, and fine powder is standby;
(6) with (3) gained volatile oil clathrate compound and (5) gained extract powder and (2) gained crude drug powder, add an amount of adjuvant mix homogeneously, the system granule, cold drying, behind the granulate, granule is standby;
(7) (6) gained granule is carried out packing, promptly.
3, the Chinese medicine granules of treatment primary hepatocarcinoma according to claim 2 is characterized in that its main constituent optimum weight percentage ratio is:
Radix Codonopsis 5.81%, Carapax Trionycis (vinegar system) 2.00%, Rhizoma Paridis 5.81%, the Rhizoma Atractylodis Macrocephalae (stir-fry) 5.81%, the Radix Astragali 5.81%, Pericarpium Citri Reticulatae 5.81%, Eupolyphaga Seu Steleophaga 1.90%, Radix Et Rhizoma Rhei 1.00%, Semen Persicae 3.90%, Herba Scutellariae Barbatae 5.81%, Herba Patriniae 5.81%, Poria 5.81%, Semen Coicis 5.81%, Radix Curcumae 5.81%, Lignum Sappan 5.81%, Concha Ostreae 5.81%, Herba Artemisiae Scopariae 5.81%, Caulis Clematidis Armandii 5.81%, Rhizoma Cyperi (system) 5.81%, Lignum Aquilariae Resinatum 1.15%, Radix Bupleuri 2.90%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410023327 CN1593522A (en) | 2004-06-18 | 2004-06-18 | Chinese traditional medicinal powder for treating primary liver cancer and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410023327 CN1593522A (en) | 2004-06-18 | 2004-06-18 | Chinese traditional medicinal powder for treating primary liver cancer and its preparing process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1593522A true CN1593522A (en) | 2005-03-16 |
Family
ID=34663405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410023327 Pending CN1593522A (en) | 2004-06-18 | 2004-06-18 | Chinese traditional medicinal powder for treating primary liver cancer and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1593522A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111388622A (en) * | 2018-12-14 | 2020-07-10 | 康普药业股份有限公司 | Ganfule capsule preparation |
-
2004
- 2004-06-18 CN CN 200410023327 patent/CN1593522A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111388622A (en) * | 2018-12-14 | 2020-07-10 | 康普药业股份有限公司 | Ganfule capsule preparation |
| CN111388622B (en) * | 2018-12-14 | 2022-12-02 | 康普药业股份有限公司 | Ganfule capsule preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1586544A (en) | Medicinal wine and its producing method | |
| CN101099763A (en) | Traditional Chinese medicine for treating headache | |
| CN1110168A (en) | Powder for curing wind-cold type of common cold and preparing method thereof | |
| CN110013470B (en) | Application of Shenbao tablet in preparing medicine for treating sequelae of pelvic inflammatory disease | |
| CN102475830A (en) | Pharmaceutical composition for treating coronary heart disease and angina pectoris, preparation method and preparation thereof | |
| CN100371012C (en) | Medicinal composition, and its preparing method and use | |
| CN1251729C (en) | Chinese herbal medicinal compositon for treating prostate disease | |
| CN1593522A (en) | Chinese traditional medicinal powder for treating primary liver cancer and its preparing process | |
| CN103239551A (en) | Freeze-dried radix rehmanniae for preventing and curing obesity | |
| CN1679899A (en) | Chinese medicine capsules for treating primary hepatocarcinoma and preparation thereof | |
| CN101912583A (en) | Medicament for treating chronic hepatitis and early-phase hepatocirrhosis and preparation method thereof | |
| CN1593523A (en) | Chinese traditional medicinal capsule for treating primary liver cancer and its preparing process | |
| CN1593521A (en) | Chinese traditional medicinal effervescence tablet for treating primary liver cancer and its preparing process | |
| CN1218741C (en) | Fingered citron particals for stomach ailment and its preparing method | |
| CN1814250B (en) | Chinese medicine composition for treating liver cirrhosis ascites and preparation method thereof | |
| CN1267137C (en) | Kidney supplementing life prolonging granules and its preparation method | |
| CN100341548C (en) | Chinese medicine formulation for treating disney disease and toxuria, and its preparing method | |
| CN1899574A (en) | Chinese medicine composition for preventing and controlling liver cancer and its use | |
| CN100482247C (en) | Improved process for producing liver-care prepns. | |
| CN1144115A (en) | Gantai tablet for curing hepatic disease | |
| CN1823925A (en) | New preparation for treating constrained liver qi | |
| CN101700323B (en) | A pharmaceutical composition for preventing and treating liver cancer | |
| CN1631414A (en) | Medicinal capsule for treating gynecological inflammation and its preparation process | |
| CN1238028C (en) | Method for preparing capsule of six drugs containing rehmannine | |
| CN108524731B (en) | Traditional Chinese medicine composition for treating myasthenia gravis and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |